Ceftizoxime open-ring Decarboxylation Impurity

INQUIRY Add to cart

For Research Use Only | Not For Clinical Use

CAT	APB04421
Synonyms	(Z)-2-((2-(2-aminothiazol-4-yl)-3-methoxyacrylamido)methyl)-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid
Molecular Weight	356.42
Molecular Formula	C13H16N4O4S2

What is the molecular weight of Ceftizoxime open-ring Decarboxylation Impurity?

The molecular weight of Ceftizoxime open-ring Decarboxylation Impurity is 356.42.

What is the molecular formula of Ceftizoxime open-ring Decarboxylation Impurity?

The molecular formula of Ceftizoxime open-ring Decarboxylation Impurity is C13H16N4O4S2.

What are some synonyms of Ceftizoxime open-ring Decarboxylation Impurity?

One of the synonyms is (Z)-2-((2-(2-aminothiazol-4-yl)-3-methoxyacrylamido)methyl)-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid.

What is the structure of Ceftizoxime open-ring Decarboxylation Impurity?

The structure of Ceftizoxime open-ring Decarboxylation Impurity is (Z)-2-((2-(2-aminothiazol-4-yl)-3-methoxyacrylamido)methyl)-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid.

What is the biological significance of Ceftizoxime open-ring Decarboxylation Impurity?

Ceftizoxime open-ring Decarboxylation Impurity is an impurity that may affect the efficacy of the drug or cause adverse reactions in biological systems.

How does Ceftizoxime open-ring Decarboxylation Impurity relate to the parent drug Ceftizoxime?

Ceftizoxime open-ring Decarboxylation Impurity is a degradation product or impurity of the parent drug Ceftizoxime.

What is the mechanism of formation of Ceftizoxime open-ring Decarboxylation Impurity?

Ceftizoxime open-ring Decarboxylation Impurity is likely formed through decarboxylation of the drug molecule.

How can Ceftizoxime open-ring Decarboxylation Impurity be detected and quantified in pharmaceutical products?

Ceftizoxime open-ring Decarboxylation Impurity can be detected and quantified using analytical techniques such as HPLC or LC-MS.

What are the potential risks associated with the presence of Ceftizoxime open-ring Decarboxylation Impurity in drug products?

The presence of Ceftizoxime open-ring Decarboxylation Impurity may lead to decreased drug potency, increased toxicity, or adverse effects on patients.

How can the formation of Ceftizoxime open-ring Decarboxylation Impurity be prevented during pharmaceutical manufacturing?

Ceftizoxime open-ring Decarboxylation Impurity formation can be prevented by optimizing manufacturing processes, storage conditions, and packaging to minimize degradation of the drug molecule.

* Products or Services Interested: Ceftizoxime open-ring Decarboxylation Impurity ()
* Your question
* Name
* Email
Verification Code

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.

Online Inquiry